Edwards Martin

DirectorVerona Pharma plc (VRNA) · full profile →Form 4 · filed Aug 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$142K
Net Open-Market Flow
-$142K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2025Option exercise(M)24K$0169K
Aug 1, 2025Sell(S)11K$13.14$142K158K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2025Option exercise(M)24K$072K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-074386) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.